• 7852 Citations
  • 44 h-Index
1974 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Timothy E Albertson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 17 Similar Profiles
Seizures Medicine & Life Sciences
Anticonvulsants Medicine & Life Sciences
Cocaine Medicine & Life Sciences
Diazepam Medicine & Life Sciences
Lindane Medicine & Life Sciences
Sepsis Medicine & Life Sciences
Rats Chemical Compounds
Poisons Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1974 2019

Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD

Albertson, T. E., Bowman, W. S., Harper, R. W., Godbout, R. M. & Murin, S., Jan 1 2019, In : International journal of chronic obstructive pulmonary disease. 14, p. 1251-1265 15 p.

Research output: Contribution to journalReview article

Open Access
Nebulizers and Vaporizers
Adrenergic Agonists
Muscarinic Antagonists
Chronic Obstructive Pulmonary Disease
Dry Powder Inhalers
1 Citation (Scopus)
Open Access
Bupropion
Metoprolol
Cocaine
Central Nervous System
Benzodiazepines
Extracorporeal Membrane Oxygenation
Oxygenation
Poisons
Membranes
Control systems

Beta-blocker overdose: Progressive treatment options

Albertson, T. E., Dorey, A. A., Richards, J. R. & Murin, S., Jan 1 2018, Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications. Nova Science Publishers, Inc., p. 121-146 26 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Equipment and Supplies
Enoximone
Intravenous Fat Emulsions
Amrinone
Milrinone

Beta-blockers in critical care and obstructive lung diseases: New directions

Kuhn, B., Stewart, E. P., Avdalovic, M. V., Albertson, T. E. & Schivo, M., Jan 1 2018, Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications. Nova Science Publishers, Inc., p. 79-106 28 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Obstructive Lung Diseases
Critical Care
Critical Illness
Guidelines
Amphetamines